Press releases

Communication is key to success, this is also true for science

Which challenges do entrepreneurs face when setting up and establishing a CRO in Europe or Asia? This essential question will be answered by our CEO Dr. Dimitrios Tzalis in the Life Science Get2Gether (LSG2G) Podcast hosted by Christian Soschner.

Read more

CARDIOMYO, the European consortium project led by ZeClinics and its partners Taros Chemicals and Amsterdam University Medical Centers, has been awarded with a budget of 2,4 million euros from the prestigious EUREKA- EUROSTARS innovation program.

Read more

A consortium comprising Grünenthal, Taros Chemicals and three research groups from the Institute for Neurosciences and Medicine (INM) of the Research Centre Jülich employed positron emission tomography (PET) as imaging method to investigate the interaction of a single drug with two specific targets…

Read more
Looking for

more information on our recent developments?

medicinal chemistry

Drug Discovery

Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…

performance chemicals

Material Science

We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications…

startseite-firstbanner

Looks interesting?

As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.